enVVeno Medical stock plummets after FDA rejects VenoValve approval

view original post

Investing.com — enVVeno Medical (TASE: BLWV) Corporation (NASDAQ: NVNO) stock plummeted 70% after the company received a not-approvable letter from the U.S. Food and Drug Administration for its …